Skip to main content
HUMASIS CO., LTD. logo

HUMASIS CO., LTD. — Investor Relations & Filings

Ticker · 205470 ISIN · KR7205470008 KO Manufacturing
Open in API
Filings indexed 333 across all filing types
Latest filing 2022-09-06 Proxy Solicitation & In…
Country KR South Korea
Listing KO 205470

About HUMASIS CO., LTD.

https://www.humasis.com/en/

Humasis Co., Ltd. is a company specializing in the research, development, and manufacturing of in-vitro diagnostic (IVD) devices, with a primary focus on Point-of-Care Testing (POCT). The company develops and produces a range of rapid diagnostic solutions, including immunodiagnostic kits for the early screening of various diseases, compact instruments for quantitative analysis, and personal health care products. A key operational strength is the in-house development and production of critical bio-materials, such as diagnostic immune antigens, which ensures the consistent performance and accuracy of its products. Humasis aims to provide technologies for precise and rapid disease analysis to support clinical decision-making and promote individual health management.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Extraordinary General Meeting' (임시주주총회 소집공고) issued by Humasis Co., Ltd. It details the meeting agenda, including board proposals for director/auditor appointments, remuneration limits, and amendments to the articles of incorporation. This document is a standard proxy statement used to inform shareholders of upcoming votes and provide necessary background information for their decision-making, which aligns perfectly with the Proxy Solicitation & Information Statement category.
2022-09-06 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a formal regulatory filing in South Korea used to solicit shareholder votes for an upcoming Extraordinary General Meeting. It contains detailed information about the meeting agenda, including board compensation, director appointments, auditor appointments, articles of incorporation amendments, and stock consolidation. This document is a proxy solicitation statement, which falls under the 'Proxy Solicitation & Information Statement' category.
2022-09-06 Korean
주식소각결정
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement regarding a 'Decision to Cancel Shares' (주식소각 결정) by Humasis. It details the number of shares to be cancelled, the method (using treasury shares), the legal basis, and the expected date of cancellation. This falls under capital structure changes related to share cancellation/buyback execution, which is best categorized as 'Share Issue/Capital Change' (SHA) as it pertains to changes in the company's issued share capital.
2022-09-01 Korean
주주총회소집결의
AGM Information Classification · 95% confidence The document is a formal notice of a shareholder meeting (주주총회소집결의) for Humasis. It outlines the date, time, location, and the fact that the agenda is yet to be finalized. This type of filing is a standard regulatory announcement regarding the scheduling of a general meeting, which falls under the category of Proxy Solicitation & Information Statement (PSI) as it relates to the formal convocation of shareholders.
2022-08-30 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming general meeting. It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal notice of the administrative procedure required for the meeting. Given its nature as a regulatory notification of a corporate event, it fits best under the RNS category.
2022-08-30 Korean
[기재정정]주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a regulatory filing from Humasis regarding the setting of a record date and shareholder register closure period for an Extraordinary General Meeting (EGM). It is a standard corporate announcement filed with the regulatory authority. Since it does not fit into specific categories like AGM-R (which is for the meeting materials themselves) or PSI (proxy solicitation), and it is a formal regulatory disclosure, it falls under the RNS category.
2022-08-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.